BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Monday, January 12, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 27, 2007
View Archived Issues
Positive interim results of Wyeth and Progenics' phase I study of oral methylnaltrexone
Read More
Oncolytics enrolls patients in U.K. combination clinical trial of Reolysin/docetaxel
Read More
Recent patents disclose novel treatment options for psychological disorders
Read More
New pharmacological solutions for immunological disorders, claimed in recent patent literature
Read More
BioLineRx and University of Illinois to develop cancer apoptosis agent
Read More
DSMB recommends BioMS' phase II MBP-8298 trial for MS continues per protocol
Read More
New PET diagnostic claimed in recent patent literature
Read More
InterMune and Roche submit amended CTA for ITMN-191 for HCV
Read More
MERITstudy compares combinations of Combivir and maraviroc or efavirenz in R5 HIV-1 infection
Read More
Tolerability of topical microbicide SPL-7013 shown in healthy males
Read More
Switzerland approves Tasigna based on efficacy in CML patients nonresponsive to Glivec
Read More
Development of alfimeprase resumes for blood clot-related disorders
Read More
Revlimid launched in U.K.
Read More
Bausch & Lomb Ireland withdraws Retisert marketing authorization application
Read More
Eli Lilly Japan files Strattera for attention deficit hyperactivity disorder in pediatric patients
Read More
Head-to-head phase IV trial compares Aptivus and darunavir
Read More
DSMB completes interim analysis of phase III study of TroVax for renal cancer
Read More
ODAC recommends FDA waits for survival results of phase III satraplatin trial
Read More
FDA places hold on tgAAC94 phase I/II study for inflammatory arthritis
Read More
Cell Therapeutics acquires Systems Medicine; gains worldwide rights to brostallicin
Read More
ICAgen files IND for novel small molecule ICA-105665 for epilepsy
Read More
Mircera approved in E.U. for treatment of anemia associated with chronic kidney disease
Read More
Novel HBsAg secretion inhibitor presented at ASV2007
Read More
Abbott's nonrefrigerated Aluvia tablets approved in 19 African countries
Read More
Summit completes name change from VASTox
Read More
Combination of ANX-201 and NRTIs proves synergistic in vitro
Read More
Positive clinical and in vitro findings presented for PRO-140 at international AIDS conference
Read More
